Serina Therapeutics (SER) Net Income Attributable to Noncontrolling Interests (2018 - 2025)
Serina Therapeutics' Income from Non-Controlling Interests was -$33,000 in FY2025, compared with -$66,000 in FY2024.
Powered by 
Analysis
Serina Therapeutics (SER) Net Income Attributable to Noncontrolling Interests (2018 - 2025) Analysis & Trends
From FY2017 onward, Serina Therapeutics has reported Income from Non-Controlling Interests for 7 years.
- The FY2025 figure marks the highest annual Income from Non-Controlling Interests in data going back to FY2017.
- Per Business Quant data, Income from Non-Controlling Interests in earlier years was -$66,000 in FY2024 and -$60,000 in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Serina Therapeutics | 23.59 Mn | -35.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | -14,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Sep 30, 2024 | -27,000.00 |
| Jun 30, 2024 | -27,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | -8,000.00 |
| Dec 31, 2022 | -58,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 7,000.00 |
| Dec 31, 2020 | -12,000.00 |
| Sep 30, 2020 | -22,000.00 |
| Jun 30, 2020 | -42,000.00 |
| Mar 31, 2020 | -35,000.00 |
| Dec 31, 2019 | -30,000.00 |
| Sep 30, 2019 | -56,000.00 |
API Access
Serina Therapeutics Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();